This is a study of two treatment pathways [Standard steroid treatment versus combined steroid and Mycophenolate (MMF)] for subjects with newly diagnosed Immune Thrombocytopenia (ITP). This study examines if it would benefit more patients if everyone takes MMF at diagnosis instead of current practice (waiting for the illness to come back).

United Kingdom

https://clinicaltrials.gov/ct2/show/NCT03156452?recrs=a&cond=ITP&draw=4&rank=27

Recruiting